CFDE Data Portal | Search RPL5P23

	Label	Description
	RPL5P23 associations Collection (Entity type)	Associations for RPL5P23_associations
	RPL5P23 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	RPL5P23 Gene (Entity type)	ENSG00000240395 - ribosomal protein L5 pseudogene 23
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193351 ruxolitinib 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE203329 HCC knockout 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 6 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE184892 trehalose fibroblast 0 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Blood 20-29 vs 70-79 Up Gene Set (Entity type)	A Gene Set from GTEx

RPL5P23 associations

Associations for RPL5P23_associations

RPL5P23 associations.tsv

A file from IDG as part of the Harmonizome project

RPL5P23

ENSG00000240395 - ribosomal protein L5 pseudogene 23

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE193351 ruxolitinib 1 v 2 human up

A Gene Set from LINCS

GSE203329 HCC knockout 2 v 1 human dn

A Gene Set from LINCS

GSE218060 decitabine T cell 1 v 3 human dn

A Gene Set from LINCS

GSE239844 crizotinib 6 v 5 human up

A Gene Set from LINCS

GSE184892 trehalose fibroblast 0 v 2 human up

A Gene Set from LINCS

GTEx Blood 20-29 vs 70-79 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.